Tag Archives: NASDAQ:KRYS

Krystal Biotech (KRYS) Gets a Buy Rating from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Krystal Biotech (KRYS – Research Report). The company’s shares closed last Monday at $45.00. According to TipRanks.com, Prasad is a 5-star analyst with an average

Krystal Biotech (KRYS) Gets a Buy Rating from Chardan Capital

In a report released today, Gbola Amusa from Chardan Capital reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), with a price target of $100.00. The company’s shares closed last Monday at $49.82. According to TipRanks.com, Amusa is

Krystal Biotech (KRYS) Receives a Rating Update from a Top Analyst

In a report released yesterday, Gbola Amusa from Chardan Capital reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), with a price target of $90.00. The company’s shares closed last Monday at $52.81. According to TipRanks.com, Amusa is

Cowen & Co. Sticks to Their Buy Rating for Krystal Biotech (KRYS)

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Krystal Biotech (KRYS – Research Report). The company’s shares closed last Monday at $43.68. According to TipRanks.com, Baral is a 5-star analyst with an

Krystal Biotech (KRYS) Receives a Buy from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Krystal Biotech (KRYS – Research Report). The company’s shares closed last Monday at $39.85. According to TipRanks.com, Prasad is a 5-star analyst with an average

Krystal Biotech Inc (KRYS) Receives a Buy from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Krystal Biotech Inc (KRYS – Research Report). The company’s shares closed last Monday at $42.20. According to TipRanks.com, Prasad is a 4-star analyst with an